LVAD clinical trials at UCSF

1 research study open to eligible people

An LVAD, or left ventricular assist device, helps a weak heart pump blood. UCSF is running trials with the HeartMate 3 to learn more about how machines can aid human hearts. These studies examine how durable LVADs are changing heart treatment.

Showing trials for

  • Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

    open to eligible people ages 18-100

    Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation…

    San Francisco, California and other locations

Last updated: